Tradestie Institutional Equity Comparison Engine

SANA vs CRBU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SANA Overall Edge

SANA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sana Biotechnology, Inc. Common Stock (SANA) driven by superior Growth & Margin, Momentum & Technical while CRBU counters with relative strength in Options & Structure. Fundamentally, SANA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CRBU at N/M Forward P/E and -1140.6% operating margin (-26.9% YoY). In options structure, SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against CRBU sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SANA N/M vs CRBU N/M Fwd P/E
Growth & Margin Winner SANA
Op Margin 0.0% vs -1140.6% ยท YoY +0.0% vs -26.9%
Momentum & Technical Winner SANA
1Y -48.6% vs -82.2% ยท 52W Pos 1% vs 0%
Options & Structure Winner CRBU
BREAKDOWN (4th %ile IV) vs BREAKDOWN (<1st %ile IV)
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0
CRBU NASDAQ
Caribou Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.35
-2.51% 1D
Market Cap $39.1M
1M Return -24.92%
1Y Return -82.23%
Forward P/E N/M
Unified AI Score
46.7 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 68.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SANA -48.63% CRBU -82.23% Spread: +33.6 pp (SANA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SANA TTM Op. Margin: 0.0% CRBU TTM Op. Margin: -1140.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANA vs CRBU. Trailing 12-month operating profitability (SANA 0.0% vs CRBU -1140.6%) and valuation multiples (SANA N/M vs CRBU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SANA (5) vs CRBU (1)
Institutional Metric SANA CRBU Criterion Row Winner
Market Capitalization Scale $605.3M $39.1M Larger Scale SANA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -26.9% Higher Growth SANA
Operating Margin (TTM) Profitability 0.0% -1140.6% Higher Margin SANA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -79.5% -93.8% Higher ROE SANA
52-Week Range Position Momentum 1% ($2โ€“$5) 0% ($0โ€“$2) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.82ฮฒ ยท 78% Vol 1.53ฮฒ ยท 94% Vol Lower Realized Risk SANA
Unified Institutional Score Composite Signal 44.3 / 100 (HOLD) 46.7 / 100 (HOLD) Higher Composite CRBU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SANA vs CRBU Buy Guide
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRBU BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CRBU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SANA nor CRBU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.